Search
for
Sort by
Research 241–270 of 1000+
- Neurosteroids, neuroactive steroids, and symptoms of affective disorders
- Updates in the understanding and treatments of skin & hair disorders in women of color
- A symphony of signals: the intricate role of lncRNAs in dermatological disorders
- Androgens in Women – Critical Evaluation of the Methods for Their Determination in Diagnostics of Endocrine Disorders
- Pharmacotherapy of polycystic ovary syndrome - an update
- Acupuncture in Polycystic Ovary Syndrome: Potential and Challenge
- Polycystic Ovary Syndrome: Management of a Long-Term Condition in Primary Care
- Characterizing hair loss in the elderly: an observational study of 163 patients
- Hyperandrogenism in Women: Polycystic Ovary Syndrome
- Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies
- Síndrome do nevo de Becker
- Therapeutic options in the polycystic ovary syndrome
- Serum C-19 steroid sulphates in females with clinical hyperandrogenism
- Efficacy and safety of a new formulation kit (shampoo + lotion) containing anti‐inflammatory and antioxidant agents to treat hair loss
- New onset of alopecia in a young woman with end-stage renal disease
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Finasteride-induced gynecomastia
- Prevalence of Non-Scarring Alopecia among Female Patients Complaining from Hirsutism
- Polycystic Ovarian Syndrome and Obstructive Sleep Apnea
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- Biochemical and trichological characterization of diffuse alopecia in women
- Acne-associated syndromes: models for better understanding of acne pathogenesis
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam’s criteria and women whose only clinical signs are oligo/anovulation or hirsutism
- Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
- Elevated serum androstenedione is associated with a more severe phenotype in women with polycystic ovary syndrome (PCOS)
- Hirsutism: diagnosis and treatment
- Antiandrogen Therapy for Skin and Hair Disease
- Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities